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A COMPARISON OF THE EFFECT OF ATROPINE AND PLACEBO ON
THE GALVANIC SKIN RESISTANCE*
DANIEL J. PERRY, M.D. AND GEORGE E. MOUNT, PH.D.
Since Fere's description in 1888 (1) of the electrical response of the skin, many
studies of this effect have been reported. This phenomenon, called the galvanic
skin response (GSR), follows a variety of stimuli and is most often measured as
a change in resistance to a direct current flow of electricity. Three major theories
have been proposed to account for the observed changes. One theory has as-
signed the response to muscular activity, another to circulatory changes within
the skin, and a third to activity of the sweat glands. At the present time, the
consensus is that the GSR is dependent on sweat gland activity, more specifically
on some presecretory change in the sweat glands (2).
Previous studies have indicated that both sweat gland activity and skin re-
sistance level are affected by various drugs. Thus, sweat-inhibiting drugs (e.g.,
atropine) have been reported to increase the level of skin resistance (3, 4, 5)
and sweat-stimulating drugs (e.g., pilocarpine) have been reported to decrease
the level of skin resistance (3, 4, 5). These early investigations do not include
a quantitative consideration of the relative effects of the different drugs or
drug dosage and do not provide data of the range of individual differences which
may be expected to occur. The control procedures and the methods used in re-
porting the data are also open to question, and for this reason do not permit a
high degree of confidence in the duplication of the results.
The present study was initiated to investigate the relative effects of atropine
and a placebo on skin resistance level. If atropine as compared to the placebo
consistently increases the level of skin resistance, the authors intend to deter-
mine the requirements for the quantification of the drug effect.
EXPERIMENTAL
Ten white male subjects ranging in age from 22 to 37 were studied. They were
all patients in a Veteran's hospital dermatologic service whose dermatitis had
disappeared and were ready for discharge from the hospital. No subject received
either oral or parenteral drugs for 48 hours prior to the experiment. Each indi-
vidual was tested in two experimental periods separated by an interval of from
two to ten days. In the experiment, the subject was placed in the circuit and a
15-minute adaptation followed; then, either a 1 cc. of physiological saline
(placebo) or I5o grain of atropine sulphate dissolved in 1 cc. of physiological
saline was injected intramuscularly. The record of resistance level was then
continued for 40 minutes.
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Instrumentation for the study consisted of a modified Wheatstone bridge illustrated in
Figure 1 with associated subject electrodes and a DC amplifier and oscillograph for re-
cording. The bridge circuit modification shown in Figure 1 insures reasonably constant
subject current and permits adjustment for balance without disturbing the bridge con-
stants.
The ouput of the bridge was coupled to a stable DC amplifier and this, in turn, was fed
into a direct writing oscillographic recorder (Esterline-Angus 1 ma. recorder Model AW).
The oscillograph chart record was calibrated to read resistance levels plus and minus 50,000
ohms on either side of the chart center which was then set at bridge balance by the adjust-
ment of resistance RI and 114 (Figure 1). In each case whera the resistance level exceeded the
limits of the chart record resistance RI was adjusted to bring the reading back to the chart
center.
The subject electrodes consisted of plastic cups enclosing a flat disk of zinc and filled
with a combination of bentonite and 5% saturated ZNSO4 in proportions to form a soft
paste. The cups were held in position over the hypothenar eminence of each palm by means
of a 1( inch wide soft rubber strap containing perforations which permitted adjustments
for the width of the subject's hand. This arrangement results in a layer of electrolyte be-
tween the skin and zinc in such a manner as to minimize polarization and the variations in
resistance due to changes in contact area and pressure without excessive restriction on the
movement of the subject's hands. This type of electrode is similar in design to that used by
Wenger (6). Figure 2 shows the equipment with the electrodes attached to a subject.
Table 1 shows the results obtained in the ten subjects tested. The resistance
levels for each record were obtained by averaging the highest and lowest re-
sistance values in a one-minute section of record. This was done to balance the
effect of momentary deflections which occur around the central resistance level.
For each control and atropine record for each subject, resistance levels were
determined beginning at 1j4 minutes prior to and at 15, 30 and 40 minutes
following the injection. These values were then converted into the square root
of conductance in order to permit grouping of the results.* This unit tends to
* has been shown that a non-linear transformation of resistance is required prior to
grouping the results for statistical purposes. The transformation to the square root of con-
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FIG. 1. Wheatstone Bridge circuit used in the measurement of subject resistance level.
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FIG. 2. Equipment with electrodes attached to a subject
correct for the non-linearity of the response and to eliminate differences between
the records which depend on different preinjection resistance levels.
RESULTS
Table 1 shows wide individual fluctuations in the relative effects of the drug
and placebo. Eight of the ten subjects had a greater decrease in the square root
of conductance (nine subjects a greater increase in resistance) 40 minutes after
atropine than after the placebo control. The group as a whole also indicates the
same trend; namely, the average change 40 minutes after the placebo is —0.14
and 40 minutes after the atropine is —1.06. Table 1 also shows that the difference
between placebo and atropine records is distinguishable at the 15-minute period
and that it increases progressively in the 30 and 40-minute periods following
the injection.
The results of this study indicate a significant increase in resistance level due
to the atropine as compared to the placebo and suggests the possibility of
evaluating the magnitude of drug effect. The results must, however, be inter-
preted with some caution because the difference between atropine and the
placebo may depend in part on the experimental order (placebo followed by
atropine). The reverse order was not included because it introduced the pos-
sibility that the side effects of atropine would influence the subsequent placebo
ductance gives an acceptable approximation to the requirements for statistical processing,
and has the additional advantage over certain other proposed transformations in that it is
more easily understood (7).
I 
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TABLE 1
Results for ten subjects using atro pine and control
Statistical significance* t (9 df); P < 0.401
1
DRUG ORDER
Placebo
Atropine
/COgANca CHANGE IN 'P/CONDUCTANCE X 10'
Prior to
injection
3.0
3.9
15 mm. after
injection
—0.2
—0.1
30 mm. after
injection
—0.3
—0.3
40 mm. after
injection
—0.2
—0.5
2 Placebo
Atropine
3.7
2.8
—0.1
—0.2
0.0
—0.1
—0.1
—0.1
3 Placebo
Atropine
4.0
4.5
—0.1
0.1
0.1
—1.3
0.0
—1.3
4 Placebo
Atropine
3.1
2.1
—0.4
—0.1
—0.9
—0.2
—0.8
—0.3
5 Placebo
Atropine
4.8
5.3
—0.6
—0.6
—0.1
—2.4
—0.5
—2.5
6 Placebo
Atropine
4.4
4.1
—0.2
—0.7
—0.1
—1.3
—0.6
—1.7
7 Placebo
Atropine
2.2
3.3
—0.1
0.1
—0.1
0.3
0.3
—0.9
8 Placebo
Atropine
4.6
5.9
0.9
—0.4
0.8
—0.5
0.2
—1.3
9 Placebo
Atropine
4.5
5.9
1.0
—0.5
—0.2
—0.5
0.6
—1.3
10 Placebo
Atropine
3.9
3.2
—0.6
0.2
—0.5
—0.1
—0.3
—0.7
Mean Placebo
Atropine
3.82
4.10
—0.04
—0.22
—0.13
—0.64
—0.14
—1.06
* Significance was computed from the standard error of the difference between scores
in the last column f or placebo and atropine.
run by making the subject apprehensive. The effect of order will be evaluated
in later studies.
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